Sunday, January 21, 2018 1:02:13 AM
I promised to text a friend after one of two things happen..
1. we get our first partnership
2. good P results
but as your post implies.. there are so many scenarios that could play out.. it would be hard
for a new investor to know how to navigate a positive run without knowing the details/structure behind
any deal.. and have some kind of grip on the science.
Traders who do not look at fundamentals will imo be at a great disadvantage (example.. my friend)..
I hate giving trading advice.. but I will encourage my friend to get out of his comfort zone and read all the dd he can.. this board (in part) has been a great resource for that.
All I will say about "personal" selling points.. if/when one of the positive scenarios starts playing out..
ONE good indication from just ONE of our platforms could easily take us through uplisting and Institutions getting involved (and of course with that comes analyst coverage.. and the inevitable momentum traders)..
it will be A LOT easier now that I have had a chance to buy these .70 shares to take a comfortable amount off after the above scenario plays itself out.. my plan now is to hold the rest for a COMPLETE buyout.
Again, great post!
p.s. petemanx.. thanks for the invite.. I don't have personal messaging on this site.. probably one good reason to take your advice. Its people like you that keep me coming back here.. despite all the other stuff..lol Good luck with your investments.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM